Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma

NCT01013324 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Cancer
Endometrial Neoplasms

Interventions

DRUG: XL147 (SAR245408)

Sponsor

Sanofi